» Articles » PMID: 31631393

Multi-site Evaluation of Partnered Pharmacist Medication Charting and In-hospital Length of Stay

Overview
Specialty Pharmacology
Date 2019 Oct 22
PMID 31631393
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To undertake a multicentre evaluation of translation of a partnered pharmacist medication charting (PPMC) model in patients admitted to general medical units in public hospitals in the state of Victoria, Australia.

Methods: Unblinded, prospective cohort study comparing patients before and after the intervention. Conducted in seven public hospitals in Victoria, Australia from 20 June 2016 to 30 June 2017. Patients admitted to general medical units were included in the study. Medication charting by pharmacists using a partnered pharmacist model was compared to traditional medication charting. The primary outcome variable was the length of inpatient hospital stay. Secondary outcome measures were medication errors detected within 24 h of the patients' admission, identified by an independent pharmacist assessor.

Results: A total of 8648 patients were included in the study. Patients who had PPMC had reduced median length of inpatient hospital stay from 4.7 (interquartile range 2.8-8.2) days to 4.2 (interquartile range 2.3-7.5) days (P < 0.001). PPMC was associated with a reduction in the proportion of patients with at least 1 medication error from 66% to 3.6% with a number needed to treat to prevent 1 error of 1.6 (95% confidence interval: 1.57-1.64).

Conclusion: Expansion of the partnered pharmacist charting model across multiple organisations was effective and feasible and is recommended for adoption by health services.

Citing Articles

Nexus of Quality Use of Medicines, Pharmacists' Activities, and the Emergency Department: A Narrative Review.

Atey T, Peterson G, Salahudeen M, Wimmer B Pharmacy (Basel). 2024; 12(6).

PMID: 39585089 PMC: 11587461. DOI: 10.3390/pharmacy12060163.


Measuring the impact of pharmaceutical care bundle delivery on patient outcomes: an observational study.

Canning M, McDougall R, Yerkovich S, Barras M, Coombes I, Sullivan C Int J Clin Pharm. 2024; 46(5):1172-1180.

PMID: 38805086 DOI: 10.1007/s11096-024-01750-w.


Partnered pharmacist medication charting and prescribing in Australian hospitals.

Tong E, Yip G Aust Prescr. 2024; 47(2):48-51.

PMID: 38737368 PMC: 11081735. DOI: 10.18773/austprescr.2024.011.


One Year Evaluation of Pharmacist Medication Charting Service in a Principal Referral Women and Newborn Hospital.

Teoh S, Mukadam N, Petrovski M Hosp Pharm. 2024; 59(2):202-209.

PMID: 38450359 PMC: 10913875. DOI: 10.1177/00185787231207752.


A cohort study comparing pharmacist activities during participation in general medical ward rounds: telehealth versus in-person during the COVID-19 pandemic.

Yap M, Edwards G, Gibbs H, Newnham H, Hancock N, Tong E Int J Clin Pharm. 2024; 46(2):522-528.

PMID: 38368283 DOI: 10.1007/s11096-024-01701-5.


References
1.
Hohl C, Dankoff J, Colacone A, Afilalo M . Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med. 2001; 38(6):666-71. DOI: 10.1067/mem.2001.119456. View

2.
Buckley M, Harinstein L, Clark K, Smithburger P, Eckhardt D, Alexander E . Impact of a clinical pharmacy admission medication reconciliation program on medication errors in "high-risk" patients. Ann Pharmacother. 2013; 47(12):1599-610. DOI: 10.1177/1060028013507428. View

3.
Lewis P, Dornan T, Taylor D, Tully M, Wass V, Ashcroft D . Prevalence, incidence and nature of prescribing errors in hospital inpatients: a systematic review. Drug Saf. 2009; 32(5):379-89. DOI: 10.2165/00002018-200932050-00002. View

4.
Barton L, Futtermenger J, Gaddi Y, Kang A, Rivers J, Spriggs D . Simple prescribing errors and allergy documentation in medical hospital admissions in Australia and New Zealand. Clin Med (Lond). 2012; 12(2):119-23. PMC: 4954094. DOI: 10.7861/clinmedicine.12-2-119. View

5.
Hajjar E, Cafiero A, Hanlon J . Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2008; 5(4):345-51. DOI: 10.1016/j.amjopharm.2007.12.002. View